Today's Top Stories | | By Jeffrey Neal Johnson | July 22, 2026 01:20 PM |
| | | By Chris Markoch | July 22, 2026 12:50 PM |
| | By Jeffrey Neal Johnson | July 22, 2026 11:00 AM |
| | | By Sam Quirke | July 22, 2026 09:50 AM |
| | By Ryan Hasson | July 21, 2026 09:05 AM |
|
|
Analysts' Upgrades | | ASGN (NYSE:EFOR) was upgraded by Truist Financial Corporation from "hold" to "buy". They now have a $36.00 price target on the stock, up from $33.00. This represents a 76.7% upside from the current price of $20.37. | | Canadian Solar (NASDAQ:CSIQ) was upgraded by Citigroup Inc. from "sell" to "neutral". They now have a $18.00 price target on the stock, up from $11.00. This represents a 16.9% upside from the current price of $15.40. | | Energy Vault (NYSE:NRGV) was upgraded by Citigroup Inc. from "neutral" to "buy". They now have a $5.00 price target on the stock, down from $5.25. This represents a 49.5% upside from the current price of $3.35. | | Fluence Energy (NASDAQ:FLNC) was upgraded by Citigroup Inc. from "neutral" to "buy". They now have a $24.00 price target on the stock, down from $26.00. This represents a 63.7% upside from the current price of $14.66. | | Genmab A/S (NASDAQ:GMAB) was upgraded by TD Cowen from "hold" to "buy". They now have a $43.00 price target on the stock, up from $32.00. This represents a 49.0% upside from the current price of $28.85. | | Grupo Aeroportuario del Centro Norte (NASDAQ:OMAB) was upgraded by JPMorgan Chase & Co. from "underweight" to "neutral". The current price is $105.35. | | Iridium Communications (NASDAQ:IRDM) was upgraded by New Street Research from "neutral" to "buy". The current price is $46.86. | | Solstice Advanced Mat (NASDAQ:SOLS) was upgraded by Vertical Research from "hold" to "buy". They now have a $79.00 price target on the stock. This represents a 30.2% upside from the current price of $60.67. |
|
View More Upgrades
|
Analysts' Downgrades | | Crown (NYSE:CCK) was downgraded by JPMorgan Chase & Co. from "overweight" to "neutral". They now have a $121.00 price target on the stock, up from $107.00. This represents a 4.0% upside from the current price of $116.37. | | Grupo Aeroportuario del Sureste (NYSE:ASR) was downgraded by JPMorgan Chase & Co. from "neutral" to "underweight". The current price is $272.93. | | Marsh & McLennan Companies (NYSE:MRSH) was downgraded by Citigroup Inc. from "buy" to "neutral". They now have a $200.00 price target on the stock. This represents a 13.5% upside from the current price of $176.27. | | Mercantile Bank (NASDAQ:MBWM) was downgraded by Hovde Group from "outperform" to "market perform". They now have a $62.00 price target on the stock. This represents a 7.3% upside from the current price of $57.80. |
|
View More Downgrades
|
Analysts' New Coverage | | Coinbase Global (NASDAQ:COIN) is now covered by Raymond James Financial, Inc.. They set a "market perform" rating on the stock. The current price is $166.12. | | Eloxx Pharmaceuticals (NASDAQ:ELOX) is now covered by Lifesci Capital. They set an "outperform" rating and a $40.00 price target on the stock. This represents a 220.8% upside from the current price of $12.47. | | Finance of America Companies (NYSE:FOA) is now covered by Alliance Global Partners. They set a "buy" rating and a $30.00 price target on the stock. This represents a 26.8% upside from the current price of $23.66. | | Generac (NYSE:GNRC) is now covered by Cantor Fitzgerald. They set an "overweight" rating and a $325.00 price target on the stock. This represents a 52.3% upside from the current price of $213.37. | | High Roller Technologies (NYSEAMERICAN:ROLR) is now covered by Alliance Global Partners. They set a "buy" rating and a $20.00 price target on the stock. This represents a 194.1% upside from the current price of $6.80. | | High Tide (NASDAQ:HITI) is now covered by D. Boral Capital. They set a "buy" rating and a $4.00 price target on the stock. This represents a 86.0% upside from the current price of $2.15. | | Immix Biopharma (NASDAQ:IMMX) is now covered by Needham & Company LLC. They set a "buy" rating and a $21.00 price target on the stock. This represents a 123.2% upside from the current price of $9.41. | | Imperial Tobacco Group (OTCMKTS:IMBBY) is now covered by BTIG Research. They set a "neutral" rating on the stock. The current price is $37.60. | | Infleqtion (NYSE:INFQ) is now covered by Craig Hallum. They set a "buy" rating and a $19.00 price target on the stock. This represents a 85.2% upside from the current price of $10.26. | | Japan Tob (OTCMKTS:JAPAY) is now covered by BTIG Research. They set a "buy" rating on the stock. The current price is $19.75. | | Nebius Group (NASDAQ:NBIS) is now covered by Robert W. Baird. They set an "outperform" rating and a $250.00 price target on the stock. This represents a 14.6% upside from the current price of $218.16. | | Nektar Therapeutics (NASDAQ:NKTR) is now covered by Canaccord Genuity Group Inc.. They set a "buy" rating and a $153.00 price target on the stock. This represents a 120.7% upside from the current price of $69.32. | | Tenax Therapeutics (NASDAQ:TENX) is now covered by Evercore Inc. They set an "outperform" rating and a $39.00 price target on the stock. This represents a 163.7% upside from the current price of $14.79. |
|
View More New Coverage
|
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| Start Your 30-Day Free Trial |
|
